A greater percentage of the tumour cells derived from MYCN shRNA‐treated mice exhibited characteristics of apoptosis, such as cell volume shrinkage, nuclear pyknosis and prominent apoptotic bodies (Figure 5D). This evidence concerns the gene MYCN and neoplasm.